Irbesartan Tablet
Product Images NDC 83008-084

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Irbesartan (NDC 83008-084). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Quality Care Products, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (150mg Label)

Label for Irbesartan Tablets USP 150 mg, containing 30 tablets. The label states the drug is for prescription use only (Rx only) and instructs to keep medication out of reach of children. It is packaged and distributed by Quality Care Products, LLC with references to manufacturing details and storage temperature instructions (68 to 77 degrees F). The label includes GTIN and NDC (83008-084-30) codes and a barcode.*

FDA Label Image

Image Description (75mg Label)

Label for Irbesartan Tablets USP 75 mg by Quality Care Products, LLC. The oral tablet packaging contains 30 tablets. The label includes the NDC 83008-085-30, storage instructions to keep at 68 to 77 degrees Fahrenheit, and manufacturer details for Camber Pharmaceuticals, Inc. and Hetero Labs Limited.*

FDA Label Image

Image2 (Camber1)

FDA Label Image

Image1 (Image1)

Chemical structure of Irbesartan, illustrating its molecular arrangement with multiple ring systems and functional groups, as shown in the product data.*

FDA Label Image

Image2 (Image2)

Two scatter plots with fitted curves showing the placebo-subtracted reduction in trough SeSBP and SeDBP versus irbesartan dose (mg/day). The left chart depicts systolic blood pressure reduction, and the right chart depicts diastolic blood pressure reduction, with dose on the x-axis and blood pressure change in mmHg on the y-axis.*

FDA Label Image

Irbesartan-figure-3 (Irbesartan Figure 3)

A line graph showing the cumulative event rate percentage over 60 months of follow-up for three treatments: Irbesartan, Amlodipine, and Placebo. The graph compares their event rates, with a key indicating relative risk (RR) and P-values for Irbesartan versus Placebo and Amlodipine.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.